VBIO

Vitality Biopharma, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/20/2017
Contact Info
  • 1901 Avenue of the Stars
  • 2nd Floor
  • Los Angeles, CA 90067

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001438943
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: NV, USA
Year of Inc. 2007
Employees 7 a/o Jul 21, 2016
Company Officers/Contacts
Robert Brooke CEO
Richard McKilligan Counsel, Controller, Corporate Secretary
Company Directors
Avtar Dhillon Chairman
Robert Brooke
Anthony E. Maida
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel
Greenberg Traurig, LLP
1201 K Street,
Suite 1100
Sacramento, CA, 95814
United States
 
Morrison & Foerster LLP
1925 Century Park East
Suite 1120
Los Angeles, CA, 90067
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Stevia First Corp. until 7-2016
  • Formerly=Legend Mining, Inc. until 10-2011
VBIO Security Details
Share Structure
Market Value1 $46,954,973 a/o Jun 23, 2017
Authorized Shares 1,000,000,000 a/o Jun 20, 2017
Outstanding Shares 20,685,010 a/o Jun 20, 2017
-Restricted 6,047,137 a/o Jun 20, 2017
-Unrestricted 14,637,873 a/o Jun 20, 2017
Held at DTC 13,849,012 a/o Jun 20, 2017
Float 18,466,590 a/o May 31, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders
Shareholders of Record 29 a/o Jul 20, 2016
Short Selling Data
Short Interest 392,437 (192.63%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security